Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Share News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

Thursday broker round-up

Thu, 07th Feb 2019 13:20
(Sharecast News) - EI Group: Peel Hunt downgrades to hold with a target price of 215p.Ferrexpo: Deutsche Bank reiterates buy with a target price of 270p.Rightmove: Deutsche Bank reiterates buy with a target price of 530p.BT: Deutsche Bank reiterates hold with a target price of 235p.CYBG: Deutsche Bank reiterates hold with a target price of 184p.Glaxosmithkline: Deutsche Bank reiterates hold with a target price of 1,520p.Compass: RBC Capital Markets reiterates outperform with a target price of 1,750p.Bellway: Peel Hunt downgrades to add with a target price of 2,945p.Superdry: Liberum reiterates hold with a target price of 400p.Barratt: Canaccord reiterates buy with a target price of 600p.Compass Group: Canaccord reiterates hold with a target price of 1,750p.Strix Group: Canaccord reiterates buy with a target price of 210p.Just Group: Barclays reiterates overweight with a target price of 149p.CYBG: Barclays reiterates underweight with a target price of 230p.Hiscox: RBC Capital Markets reiterates sector performer with a target price of 1,600p.

Related News

LONDON MARKET CLOSE: Vodafone lifts FTSE 100 as easyJet backs new bid
1 hour ago

LONDON MARKET CLOSE: Vodafone lifts FTSE 100 as easyJet backs new bid

(Alliance News) - The FTSE 100 closed higher on Friday in calmer trading, boosted by double-digit gains from telecommunications firm Vodafone.

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
3 hours ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
4 hours ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

Ferrexpo News

Ferrexpo says climate "highly constrained", still seeks funding
29 Jun 2026

Ferrexpo says climate "highly constrained", still seeks funding

(Alliance News) - Ferrexpo PLC on Monday said its production and export activities continue in Ukraine, despite the challenging environment, although ...

TRADING UPDATES: Conduit CFO Whelan to step down in September
28 Apr 2026

TRADING UPDATES: Conduit CFO Whelan to step down in September

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

Ferrexpo shares face suspension after delay to $100m fundraising
28 Apr 2026

Ferrexpo shares face suspension after delay to $100m fundraising

(Sharecast News) - Ferrexpo warned on Tuesday that its shares faced suspension, following a delay to a vital $100m fundraising.

LONDON MARKET OPEN: BP leads as FTSE mixed on Iran talks drift
28 Apr 2026

LONDON MARKET OPEN: BP leads as FTSE mixed on Iran talks drift

(Alliance News) - Stock prices in London opened mixed on Tuesday, with gains among energy stocks offsetting weakness in banks and mid-caps.

LONDON BRIEFING: BP and Barclays lift profit and shareholder returns
28 Apr 2026

LONDON BRIEFING: BP and Barclays lift profit and shareholder returns

(Alliance News) - Barclays reports a rise in first-quarter profit and announces a new share buyback, BP delivers earnings growth and a higher dividend...

LONDON MARKET MIDDAY: FTSE 100 edges up on mixed signals from Iran
22 Apr 2026

LONDON MARKET MIDDAY: FTSE 100 edges up on mixed signals from Iran

(Alliance News) - Stock prices in London were mixed at midday on Wednesday amid choppy trading, as investors continued to weigh mixed messages coming ...